Journals | Policy | Permission

Journal of Medical Cases

Case Report

Volume 11, Number 10, October 2020, pages 324-326

A Cervical Smear Scare due to Monsel’s Solution: A Case Report

Monsel’s solution (20% aqueous ferric subsulphate) has been in use in medicine for decades for its styptic qualities to secure hemostasis. It is popular amongst gynecologists performing cervical biopsies and excisions, as well as dermatologists performing punch biopsies. Leon Monsel, a French pharmacist, first described the styptic qualities of ferrous subsulphate in 1852 during the Crimean War [1]. Monsel’s solution was initially used for disruptions of the epithelium, which were numerous during wartime [2]. Ferric subsulphate was then compared to ferrous chloride for hemostasis in a study published in the Archives of Dermatology. The authors concluded that its hemostatic effect was due to mechanical sealing of small vessels, rather than the acidic background. By reacting ferric sulphate with sulphuric acid and nitric acid, with a pH approaching 1, the brown acidic Monsel’s solution is created [3]. Its use as a hemostatic agent has been explored beyond cervical biopsies and excision procedures in gynecology. Monsel’s solution has been proposed as a treatment option for obstetric hemorrhage, where it is applied directly to the placental bed in a case of focal placenta accreta [4]. However, one has to be really careful when examining a cytology or histology specimen that has had a recent “interference” from Monsel’s solution, as failure to recognize its related artifact may lead to diagnostic problems, in particular overcalling of cervical smear resulting in false positive diagnosis of a cervical malignancy.

A 28-year-old nulliparous woman with a history of adenomyosis presented to the Urgent Obstetrics and Gynecology Clinic (UOGC) for sudden heavy intermenstrual bleeding. The bleeding had begun as a mild brown vaginal discharge 7 days earlier, which had now become acutely heavy. She had completed her menses, which lasted 3 days, just 12 days prior. She has never had intermenstrual bleeding before. There was no provoking trauma or recent sexual intercourse.

Pelvic examination revealed a cervix with a Nabothian cyst at the posterior lip, which was actively oozing. The uterus felt bulky and adenomyotic, and the cervix felt smooth. Monsel’s solution, along with compression, was applied onto the cervix, and the bleeding stopped.

She returned 3 days later for a review. The heavy vaginal bleeding had recurred since a day earlier. Pelvic examination showed active oozing from a 2-cm Nabothian cyst in the posterior cervix, which was otherwise smooth. A cervical smear and a human papillomavirus (HPV) swab were taken. Vaginal packing was inserted, which stopped the bleeding.

Although the HPV test was negative, the cervical smear result showed atypical cells, suspicious for malignancy. In particular, the smear showed a hemorrhagic diathesis (Fig. 1), in which scattered atypical keratinized cells were noted (Fig. 2), leading to a suspicion for malignancy. She was referred for colposcopy.

Click for large image

Figure 1. Cervical smear showing a background of hemorrhagic diathesis.

Click for large image

Figure 2. Occasional spindled squamous cells with hyperchromatic nuclei (red arrow) are seen resembling keratinized squamous cells commonly seen in association with invasive squamous cell carcinoma. Polymorphonuclear cells with enlarged nuclei, conspicuous nucleoli and coarse chromatin (green arrows) are seen in the background.

Colposcopy was adequate with a type 1 transformation zone. A grade 2 acetowhite lesion and a nodule were seen in the posterior cervix, but with no mosaicism, punctation, or atypical vessels. Clinical impression was that of possible cervical intraepithelial neoplasia (CIN) III/microinvasive disease. Punch biopsies taken showed CIN I and koilocytosis. p16 block positivity was not demonstrated. The patient was counselled regarding the discrepancy in results and agreed for a laser cone biopsy of the cervix to exclude malignancy.

During the laser cone biopsy, multiple deep Nabothian cysts were noted at the 8 to 10 o’clock positions. A 15 × 15 × 12 mm cone biopsy specimen was obtained. The final histology showed CIN I with clear margins. There was no cervical glandular intraepithelial neoplasia (CGIN) or invasive malignancy. A repeat smear 3 months after the cone biopsy showed atypical squamous cells of undetermined significance (ASCUS) and the repeat HPV test was negative.

The patient made a full recovery from the laser cone biopsy and had a levonorgestrel intrauterine system (LNG-IUS) inserted to reduce her heavy menstrual bleeding due to adenomyosis.

The discrepancy between the initial cervical smear and the final laser cone histology prompted a multidisciplinary discussion involving the gynecologist and the pathologist during which the patient’s history and chronology of events were reviewed. It was discovered that Monsel’s solution had been applied to the cervix to stop the Nabothian cyst from bleeding, just 3 days before the cervical smear was taken. The conclusion was that Monsel’s solution had caused the hemorrhagic diathesis and artifactual changes to squamous cells (Fig. 2), which mimicked the appearance of a cervical squamous cell carcinoma. The patient had even contemplated a hysterectomy but was relieved to know that the discrepant results were due to Monsel’s solution-related artifact.

Monsel’s solution is an effective topical hemostatic agent, especially ideal for stopping small amounts of bleeding of the cervix or epithelium. Its ability to achieve hemostasis in less than 20 seconds has ensured its wide use in gynecology [5]. Monsel’s solution causes tissue necrosis and impedes re-epithelialization. In the healing phase, granulation tissue, siderophages and ferrugination (i.e., the deposition of ferric salts within fibrin, dermal collagen and striated muscle) are present. Occasionally, a foreign body type reaction to the pigment and necrotic tissue may be seen.

The histologic effect of Monsel’s may persist for at least 3 weeks in tissue; hence this may interfere with the ability to recognize and characterize the disease process [6]. If a cervical smear is taken within 3 weeks after the application of Monsel’s solution, the changes described above will be reflected in the smear: tumor/hemorrhagic diathesis, spindling of squamous cells and atypical reactive squamous cells showing enlarged nuclei with conspicuous nucleoli (Fig. 2). These cytological features may lead to overcalling of the smear resulting in a false positive diagnosis of invasive squamous cell carcinoma.

Knowing the above, it is prudent to avoid performing a cervical smear on a patient who had just recently been treated with Monsel’s solution on the cervix, to avoid confusion in interpreting the cytology. In cases where an urgent smear or biopsy has been taken within a few weeks after Monsel’s solution application, this must be highlighted to the pathologist to avoid misinterpretation of the cytologic or histologic findings. Close communication between gynecologist and pathologist is key to avoid misinterpretation of cytology or histology specimens, so as to avoid causing undue anxiety to the patient.

Acknowledgments

None to declare.

Financial Disclosure

None to declare.

Conflict of Interest

None to declare.

Informed Consent

Informed consent was obtained from the patient.

Author Contributions

MFAR is involved in data collection, literature review and case write-up. WWL and CSH are involved in supervision and final editing. YYC is involved in supervision, images editing and final editing.

Data Availability

The data supporting the findings of this study are available from the corresponding author upon reasonable request.

1. Proctor W. Remarks on Monsel's persulphate of iron. Am J Pharmacol. 1859;31:403-407.
2. Garrett AP, Wenham RM, Sheets EE. Monsel's solution: a brief history. J Low Genit Tract Dis. 2002;6(4):225-227.
   doi pubmed
3. Amazon K, Robinson MJ, Rywlin AM. Ferrugination caused by Monsel's solution. Clinical observations and experimentations. Am J Dermatopathol. 1980;2(3):197-205.
   doi pubmed
4. Miller DT, Roque DM, Santin AD. Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents. Am J Obstet Gynecol. 2015;212(6):725-735.
   doi pubmed
5. Capacho A, Alcobia A. PP-004 compounded Monsel's agent in gynaecology procedures. Eur J Hosp Pharm. 2014;21:A123-A124.
   doi
6. Spitzer M, Chernys AE. Monsel's solution-induced artifact in the uterine cervix. Am J Obstet Gynecol. 1996;175(5):1204-1207.
   doi

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Journal of Medical Cases is published by Elmer Press Inc.